Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_assertion type Assertion NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_head.
- NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_assertion description "[MAGE-1 and MAGE-3 or -6 were expressed in 5/14 (36%) and 6/14 (43%) neuroblastoma (NB) cell lines, and in 20/41 (49%) and 24/41 (59%) clinical NB-related tumors, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_provenance.
- NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_assertion evidence source_evidence_literature NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_provenance.
- NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_assertion SIO_000772 8900370 NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_provenance.
- NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_assertion wasDerivedFrom befree-20140225 NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_provenance.
- NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_assertion wasGeneratedBy ECO_0000203 NP905583.RAXR2v77eF6ywgV2DBlzz2sD2leAHGGZMeEs4I_VTHrkQ130_provenance.